Most Common Types of Gynecologic Cancers

  • Endometrial/Uterine is the most common GYN cancer. The primary symptom of endometrial cancer is abnormal bleeding.
  • Ovarian cancer is the second most common GYN cancer. Since there are no effective screening tests, one must be aware of the earliest symptoms of ovarian cancer.
  • Cervical cancer has been steadily decreasing in incidence with the increased prevalence of pap smear screening. We encourage you to get an annual pap smear.

Signs and Symptoms of Ovarian Cancer

    Recent studies have shown that most women with ovarian cancer have had some or all of the following symptoms almost daily for more than a few weeks:

  • Bloating
  • Pelvic or abdominal pain
  • Urinary urgency or frequency
  • Difficulty eating or feeling full quickly
  • The key is whether that is change from normal for your body.

    Other symptoms can include fatigue, indigestion, back pain, pain with intercourse, constipation, and menstrual irregularity.

    Because the signs and symptoms of GYN cancers may also be associated with other conditions such as irritable bowel syndrome, it is important that your physician take seriously the possibility that ovarian cancer may be present, especially if you have a family or personal history of ovarian, breast, or colon cancer, and have never borne children.

    If you should have these symptoms, please see your gynecologist, who can follow-up with some diagnostic tests - CA125, transvaginal ultrasound, and pelvic exam. If these results indicate the possibility of ovarian cancer, ask - no, insist - to be referred to a gyn oncologist.

UAB Receives Grant for Cervical Cancer

UAB will be one institution testing 4 vaccines -- 2 are aimed at prevention of cervical cancer, one that is aimed at pre-invasive cervical cancer, and one at invasive cervical cancer. Read more about it at the link below.

Click here.

UAB Researcher Selected for Inaugural Ovarian Cancer Academy Award

A researcher in the UAB Comprehensive Cancer Center has been selected for the inaugural Ovarian Cancer Academy Award, part of the U.S. Department of Defense funding for cancer research. Assistant Professor Charles Landen, M.D., of the Division of Gynecologic Oncology, is one of seven early career investigators chosen for the grant. The award is $1.06 million from the Office of Congressionally Directed Medical Research.

Landen works to identify and characterize a subpopulation of ovarian cancer cells that have enhanced ability to survive chemotherapy and cause recurrence. Understanding this class of cells may lead to discoveries of key pathways than can be targeted with novel anti-cancer therapies.

This five-year defense award is part of the Office of the Congressionally Directed Medical Research managed by the U.S. Army Medical Research and Materiel Command.

The Office of Congressionally Directed Medical Research Programs was born from a powerful grassroots effort led by the breast cancer advocacy community that convinced Congress to appropriate funds for breast cancer research, according to a statement. This enabled a unique partnership among the public, Congress and the military. Created within the U.S. Army Medical Research and Materiel Command to manage these critical funds, the program office has grown to encompass multiple targeted programs and has received billions in appropriations from its inception through fiscal year 2010.

The UAB Comprehensive Cancer Center is among the 40 cancer centers in the nation to meet the stringent criteria for the National Cancer Institute.s comprehensive designation. The center is a leader in groundbreaking research, reducing cancer disparities and leading-edge patient care.

August 25, 2010